Biosensors for Public Health
Cell-free biological technology for on-site detection of pathogens.
COVID-19 detection kits will be available soon.
Laboratory Testing Does Not Scale
Traditional laboratory testing can take weeks and cost hundreds of dollars to get results. This is due to centralized testing infrastructure that requires sample transportation, complicated equipment, and technical expertise. These high costs and time delays are unacceptable for threats like pathogens, toxins, and chemical contaminants that require immediate answers.
At Stemloop, we repurpose these biological mechanisms to create sensors that function outside of a cell. These “cell-free” biosensors enable rapid, low-cost solutions for the on-site detection of pathogens and chemical contaminants. In contrast to laboratory testing, Stemloop’s cell-free biosensors can be scaled up and widely deployed for high-resolution public health surveillance.
The ability to detect SARS-CoV-2 exemplifies how difficult it is to scale laboratory testing and how failures can result in public health crises and major economic losses. Leveraging our deep expertise in the development of easy-to-use cell-free biosensors, Stemloop is developing a test platform for the rapid, on-site detection of SARS-CoV-2.
Get notified when our COVID-19 detection kits are available
OUR STORY & TEAM
At Stemloop, our mission is simple: enable anyone, anywhere, to sense the world around them through cell-free biological technology.
Khalid K. Alam, Ph.D.
Co-founder & President
Julius Lucks, Ph.D.
Business Development & Operations
Mike Jewett, Ph.D.
Dick Co, Ph.D.
Learn more about how Stemloop’s platform technologies
can work for you.
Please reach out with any questions.
P.O. Box 5805
Evanston, IL 60204
© Stemloop, 2020